Solubility based Biowaiver [Dissolution / BCS / IVIVC]

posted by Amalia – Greece, 2018-10-02 12:35 (2056 d 04:16 ago) – Posting: # 19362
Views: 6,057

❝ Where is the difference coming from?


None of the excipients are proportional.

❝ Is the API less than 5% of the total weight of the tablet?


The API of the lowest strength is less than 5%. But not of the highest strength for which a BE study was performed.

❝ Take a look at the General biowaiver criteria on page 12 of the guideline. If you don't meet the conditions stated in c), you'll need to conduct a BE study at the lower strength too.


I Know. The most probable scenario is that we will perform a BE study. We are just trying to see if a justification can be made.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,029 posts in 4,834 threads, 1,644 registered users;
38 visitors (0 registered, 38 guests [including 7 identified bots]).
Forum time: 16:52 CEST (Europe/Vienna)

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5